Cargando…
Effects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model
INTRODUCTION: Despite the widespread use of the mouse transverse aortic constriction heart failure model, there are no reports on the characterization of the standard-of-care agent carvedilol in this model. METHODS: Left ventricular pressure overload was produced in mice by transverse aortic constri...
Autores principales: | Hampton, Caryn, Rosa, Raymond, Szeto, Daphne, Forrest, Gail, Campbell, Barry, Kennan, Richard, Wang, Shubing, Huang, Chin-Hu, Gichuru, Loise, Ping, Xiaoli, Shen, Xiaolan, Small, Kersten, Madwed, Jeffrey, Lynch, Joseph J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406154/ https://www.ncbi.nlm.nih.gov/pubmed/28491305 http://dx.doi.org/10.1177/2050312117700057 |
Ejemplares similares
-
Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017) -
Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008) -
Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015) -
Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation
por: Tian, Xiaopeng, et al.
Publicado: (2017) -
Distinct Phenotypes Induced by Three Degrees of Transverse Aortic Constriction in Mice
por: Richards, Daniel A., et al.
Publicado: (2019)